St. Louis, MO (PRWEB) August 31, 2014
A morcellator lawsuit filed in U.S. District Court in California’s Northern District* will move forward this September. The two parties’ legal counsels are set to convene for a Case Management Conference on September 26, 2014 at 10:00 a.m., according to court documents. Attorneys handling morcellator claims offer frequent morcellator lawsuit news and comprehensive morcellator claims information at the Morcellator Cancer Lawsuit Center website.
The plaintiffs, Sarah Salem-Robinson and her husband Alan A. Robinson, filed suit against Richard Wolf Medical Instruments Corporation after Ms. Salem-Robinson was diagnosed with uterine cancer. The plaintiff underwent a supracervical hysterectomy surgery via power morcellator in May of 2012.
Salem-Robinson filed the morcellator lawsuit on May 13, 2014 against Richard Wolf Medical Instruments Corporation, the manufacturer of the Wolf Power Morcellator that was used to perform her surgery, according to court documents. Prior to her surgery, Ms. Salem-Robinson claims her doctor told her that fibroids in her uterus were not cancerous. However, according to court documents, she was diagnosed with cancer just two weeks after the procedure, on May 30, 2012. One of the fibroids was in fact a cancerous tumor, known as leiomyosarcoma.
The use of a power morcellator minces tissues in order to remove them through tiny incisions. When cancer cells are operated on with a power morcellator, there is a great risk of spreading the cancer throughout the pelvis and abdomen, according to an FDA Safety Communication** issued on April 17, 2014. Federal regulators discourage the use of power morcellators for laparoscopic gynecologic surgeries such as hysterectomy and myomectomy due to the risk of spreading undetected cancer.
The FDA concluded that 1 in 350 women has unsuspected or undetected uterine sarcoma at the time of morcellation, a number that is far higher than previously thought. Furthermore, there is no reliable method for detecting uterine cancer prior to performing surgery. Through morcellator surgery, a contained, relatively treatable uterine sarcoma can be transformed into an advanced-stage form of the disease that threatens the patient’s life, according to the April 17, 2014 FDA news release*** on the agency’s cancer findings.
The Onder Law Firm, respected throughout the country for its superior work in family and product liability law, provides comprehensive information on morcellator surgery lawsuits at MorcellatorCancerLawsuitCenter.com. The morcellator attorneys offer no-cost, confidential case reviews to women and the family members of women who were diagnosed with cancer following morcellator surgery. Attorneys reviewing morcellator claims believe women who were diagnosed with cancer following hysterectomy or myomectomy surgery may be entitled to real compensation for the harm and damages they sustained.
The Onder Law Firm welcomes morcellator lawsuit inquiries from law firms in regards to handling them or working as co-counsel.
About The Onder Law Firm
Onder, Shelton, O’Leary & Peterson, LLC is a St. Louis based personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The pharmaceutical and medical device litigators at The Onder Law Firm have represented thousands of Americans in lawsuits against multinational conglomerates from products liability for manufacture of defective or dangerous products to deceptive advertising practices. Other firms throughout the nation often seek its experience and expertise on complex litigation. It is also a recognized leader in products liability cases such as window blind cord strangulation. The Onder Law Firm offers information from morcellator surgery lawyers at http://www.morcellatorcancerlawsuitcenter.com.
*Case 5:14-cv-02209-EJD - Salem-Robinson et al v. Richard Wolf Medical Instruments Corporation